Gen II FemCap Commercialization
Contraception
ApprovedActive
Key Facts
About FemCap
FemCap is a long-standing private company commercializing a single, FDA-approved medical device: a non-hormonal cervical cap for contraception. Its strategy leverages direct-to-consumer e-commerce and telehealth for sizing and distribution, targeting women seeking alternatives to hormonal birth control and emphasizing autonomy, comfort, and environmental sustainability. The company's commercial success hinges on effective digital marketing, user education, and competing within the niche but growing market for non-hormonal, user-controlled contraceptive methods.
View full company profileTherapeutic Areas
Other Contraception Drugs
| Drug | Company | Phase |
|---|---|---|
| Drosperinone + Ethinyl Estradiol Tablets | BDR Pharmaceuticals | Commercial |
| Eucontra | Hera Health Solutions | Filed |
| 3Daughters IUD | 3Daughters | Pre-clinical |
| Twirla® (levonorgestrel/ethinyl estradiol) | Agile Therapeutics | Approved |
| Copper 175 mm² IUD | Sebela Pharmaceuticals | Phase 3 |
| SiRx‑Contraception | SiCare Bio | Discovery |
| Novel Oral Contraceptive Combinations | RPG Life Sciences | Formulation Development |
| AYA™ (etonogestrel) contraceptive vaginal system | Organon | Filed |